Balance Sheet Data

Dermapharm Holding SE (DMP.DE)

47.14 €

-0.38 (-0.80%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 6.69213.91116.04121.66173.17200.27238.83284.82339.67405.08
Total Cash (%)
Account Receivables ----------
Account Receivables (%)
Inventories 81.11115.56172.17203.26240.54254.65303.69362.17431.91515.09
Inventories (%)
Accounts Payable 23.3728.1835.3650.3752.1060.3671.9985.85102.38122.10
Accounts Payable (%)
Capital Expenditure -74.71-25.97-46.44-40.80-61.20-87.23-104.03-124.07-147.96-176.45
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.